A novel defined cuproptosis‑related signature score to predict prognosis and immunotherapy efficacy in pancreatic cancer
Oncology Letters · 14.10.2025 · 30 (6) · 1-14
DOI: 10.3892/ol.2025.15337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 14.10.2025. Verfasst von Weiyu Ge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China.
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China.
Zitieren
APA
Ge, W., Wang, Y., Shentu, D., Yue, M., & Wang, Y. (2025). A novel defined cuproptosis‑related signature score to predict prognosis and immunotherapy efficacy in pancreatic cancer. Oncology Letters, 30(6), 1-14. https://doi.org/10.3892/ol.2025.15337
Vancouver
Ge W, Wang Y, Shentu D, Yue M, Wang Y. A novel defined cuproptosis‑related signature score to predict prognosis and immunotherapy efficacy in pancreatic cancer. Oncology Letters. 2025;30(6):1-14. doi:10.3892/ol.2025.15337
BibTeX
@article{Ge2025,
author = {Ge, Weiyu and Wang, Yongchao and Shentu, Daiyuan and Yue, Ming and Wang, Yanling},
title = {A novel defined cuproptosis‑related signature score to predict prognosis and immunotherapy efficacy in pancreatic cancer},
journal = {Oncology Letters},
year = {2025},
volume = {30},
number = {6},
pages = {1--14},
doi = {10.3892/ol.2025.15337}
}
EUVIMED